United Kingdom Liver Cancer Market Insight
Published: 08 June 2026 | Report Format: Electronic (PDF)
United Kingdom Liver Cancer Market is projected to grow at a CAGR of around 6.5%, driven by rising liver cancer prevalence, increasing adoption of targeted therapies, immunotherapies, early diagnosis, and advanced treatment technologies.
United Kingdom Liver Cancer Market Forecasts to 2035
- The United Kingdom Liver Cancer Market size was estimated at approximately USD 0.85 Billion in 2025.
- The market is expected to grow at a CAGR of around 6.5% from 2025 to 2035.
- The United Kingdom Liver Cancer Market is projected to reach approximately USD 1.7 Billion by 2035.
Notable Insight the United Kingdom Liver Cancer Market
- Based on treatment type segmentation, targeted therapy, immunotherapy, chemotherapy, surgery, and radiation therapy constitute major treatment approaches, with targeted therapies accounting for nearly 38% of market revenue in 2025.
- Based on cancer type segmentation, hepatocellular carcinoma (HCC) remains the dominant segment, representing nearly 76% of total diagnosed liver cancer cases in 2025.
- The market is increasingly driven by advancements in precision oncology and biomarker-based treatments, while leading pharmaceutical companies collectively account for nearly 58% of total market revenue.
- Growing adoption of immunotherapy and combination treatment regimens is accelerating market growth, with advanced therapies contributing nearly 35% of treatment-related revenue in 2025.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- Intelligent Market Research Based on AI for Semiconductors & Optoelectronics
Decisions Advisors offers intelligent market research which includes advanced analysis of infrared sensor technologies, optoelectronic semiconductors, AI-driven sensing solutions, and remote sensing. Our research identifies potential areas of business development, technology adoption rates, competitive position analysis, and important strategic changes in South Korea Remote Sensing Infrared Light Emitting Diode Market.
- Highly Effective Research Approaches with Accurate Forecast Analysis
The research process uses advanced methodologies such as primary research interview approaches, industry research, tracking the semiconductor value chain, and data triangulation to deliver accurate market sizing, CAGR forecasting, investment analysis, and technology forecasting. The study examines the demand for semiconductor solutions in automotive electronics, industrial automation, health care monitoring, and smart surveillance applications in South Korea.
- Highly Competitive Environment Analysis
In-depth analysis of key infrared LED players, optoelectronic semiconductor innovations, AI-enabled sensing solutions, product launch activities, and collaborations is included in the report. The report also covers semiconductor regulations, technology research and development analysis, smart sensor infrastructure, and new opportunities available in the South Korea Remote Sensing Infrared Light Emitting Diode Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Liver Cancer Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies United Kingdom Liver Cancer Market
- AstraZeneca
- Bristol Myers Squibb
- Roche
- Merck & Co.
- Eisai Co., Ltd.
- Bayer AG
- Pfizer Inc.
- Novartis AG
- Eli Lilly and Company
- Johnson & Johnson
Recent Developments:
- In March 2025, oncology companies expanded clinical development programs for next-generation immunotherapies targeting advanced liver cancer patients.
- In February 2025, healthcare providers increased adoption of precision medicine approaches and biomarker testing to improve treatment outcomes and patient selection.
Market Segmentation:
United Kingdom Liver Cancer Market, By Treatment Type
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Surgery
- Radiation Therapy
United Kingdom Liver Cancer Market, By Cancer Type
- Hepatocellular Carcinoma (HCC)
- Intrahepatic Cholangiocarcinoma
- Other Liver Cancers
United Kingdom Liver Cancer Market, By End User
- Hospitals
- Cancer Treatment Centers
- Specialty Clinics
- Research Institutes
Expert Views:
The United Kingdom Liver Cancer Market is expected to witness strong growth through 2035, supported by increasing disease prevalence, rising awareness of early detection, and growing adoption of advanced oncology therapies. Continuous innovation in immunotherapy, targeted treatments, precision medicine, and biomarker-based diagnostics is expected to improve patient outcomes and strengthen long-term market expansion across the UK healthcare sector.
Author: Komal and Radhika By Spherical Insights and Consulting